Japan Aviation Electronics Industry, Limited (TYO:6807)
Japan · Delayed Price · Currency is JPY 2,492.00
+62.00 (2.55%)
Aug 1, 2025, 3:30 PM JST
CTI BioPharma Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 217,689 | 221,644 | 225,781 | 235,864 | 225,079 | 209,711 | Upgrade | |
Revenue Growth (YoY) | -5.19% | -1.83% | -4.28% | 4.79% | 7.33% | 0.77% | Upgrade |
Cost of Revenue | 178,098 | 179,580 | 185,999 | 193,657 | 183,135 | 180,396 | Upgrade |
Gross Profit | 39,591 | 42,064 | 39,782 | 42,207 | 41,944 | 29,315 | Upgrade |
Selling, General & Admin | 26,269 | 25,782 | 24,703 | 23,981 | 23,298 | 19,965 | Upgrade |
Operating Expenses | 26,269 | 26,448 | 25,358 | 24,644 | 23,894 | 20,608 | Upgrade |
Operating Income | 13,322 | 15,616 | 14,424 | 17,563 | 18,050 | 8,707 | Upgrade |
Interest Expense | -649 | -635 | -62 | -81 | -107 | -94 | Upgrade |
Interest & Investment Income | 901 | 888 | 486 | 241 | 159 | 279 | Upgrade |
Currency Exchange Gain (Loss) | -568 | -595 | 1,292 | 1,712 | 905 | -530 | Upgrade |
Other Non Operating Income (Expenses) | 53 | 106 | -446 | 221 | 168 | 252 | Upgrade |
EBT Excluding Unusual Items | 13,059 | 15,380 | 15,694 | 19,656 | 19,175 | 8,614 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 33 | Upgrade |
Gain (Loss) on Sale of Assets | - | -197 | 1,099 | -542 | -581 | -767 | Upgrade |
Asset Writedown | -499 | - | -400 | - | - | - | Upgrade |
Pretax Income | 12,560 | 15,183 | 16,393 | 19,114 | 18,594 | 7,880 | Upgrade |
Income Tax Expense | 3,248 | 3,591 | 4,148 | 4,475 | 4,269 | 2,188 | Upgrade |
Net Income | 9,312 | 11,592 | 12,245 | 14,639 | 14,325 | 5,692 | Upgrade |
Net Income to Common | 9,312 | 11,592 | 12,245 | 14,639 | 14,325 | 5,692 | Upgrade |
Net Income Growth | -27.71% | -5.33% | -16.35% | 2.19% | 151.67% | -48.91% | Upgrade |
Shares Outstanding (Basic) | 67 | 67 | 89 | 91 | 91 | 91 | Upgrade |
Shares Outstanding (Diluted) | 67 | 67 | 89 | 91 | 91 | 91 | Upgrade |
Shares Change (YoY) | -19.22% | -24.60% | -1.88% | 0.12% | 0.04% | 0.01% | Upgrade |
EPS (Basic) | 138.19 | 172.05 | 137.07 | 160.77 | 157.46 | 62.58 | Upgrade |
EPS (Diluted) | 138.14 | 171.97 | 136.98 | 160.69 | 157.42 | 62.58 | Upgrade |
EPS Growth | -10.51% | 25.54% | -14.75% | 2.08% | 151.55% | -48.91% | Upgrade |
Free Cash Flow | - | 18,294 | 14,489 | 9,882 | 5,473 | 10,926 | Upgrade |
Free Cash Flow Per Share | - | 271.40 | 162.08 | 108.47 | 60.15 | 120.12 | Upgrade |
Dividend Per Share | 60.000 | 60.000 | 55.000 | 50.000 | 35.000 | 25.000 | Upgrade |
Dividend Growth | 9.09% | 9.09% | 10.00% | 42.86% | 40.00% | -37.50% | Upgrade |
Gross Margin | 18.19% | 18.98% | 17.62% | 17.89% | 18.63% | 13.98% | Upgrade |
Operating Margin | 6.12% | 7.05% | 6.39% | 7.45% | 8.02% | 4.15% | Upgrade |
Profit Margin | 4.28% | 5.23% | 5.42% | 6.21% | 6.36% | 2.71% | Upgrade |
Free Cash Flow Margin | - | 8.25% | 6.42% | 4.19% | 2.43% | 5.21% | Upgrade |
EBITDA | 34,255 | 36,490 | 35,062 | 38,118 | 38,470 | 29,948 | Upgrade |
EBITDA Margin | 15.74% | 16.46% | 15.53% | 16.16% | 17.09% | 14.28% | Upgrade |
D&A For EBITDA | 20,933 | 20,874 | 20,638 | 20,555 | 20,420 | 21,241 | Upgrade |
EBIT | 13,322 | 15,616 | 14,424 | 17,563 | 18,050 | 8,707 | Upgrade |
EBIT Margin | 6.12% | 7.04% | 6.39% | 7.45% | 8.02% | 4.15% | Upgrade |
Effective Tax Rate | 25.86% | 23.65% | 25.30% | 23.41% | 22.96% | 27.77% | Upgrade |
Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.